Full Breakdown
Nursing Homes Accused of Falsely Diagnosing Schizophrenia to Justify Antipsychotic Drug Use
3/24/2026, 2:58:04 AM
Overview of the Investigation
A recent report from the Office of Inspector General (OIG) at the U.S. Department of Health and Human Services (HHS) has raised serious allegations against some U.S. nursing homes for falsely diagnosing patients with schizophrenia. This practice appears to be a strategy to justify the use of powerful antipsychotic medications, particularly for residents with dementia, which are not approved for such conditions. The investigation reviewed inspection reports from 40 nursing homes and found that this misdiagnosis may be used to obscure the actual frequency of antipsychotic drug administration.
Findings of the Report
The OIG report indicates that nursing homes may be misusing schizophrenia diagnoses to enhance their ratings on the Medicare website, as these diagnoses do not count against them in government quality measures. The report highlights that antipsychotic medications carry significant risks, including falls, strokes, and death, yet they are often prescribed off-label. Alarmingly, the report notes instances where residents received these medications for non-dangerous behaviors, such as a 100-year-old woman being medicated for enjoying caring for dolls.
Investigators found that some facilities resorted to adding schizophrenia diagnoses to patient records without proper evaluation or family notification. In one case, a nurse practitioner reportedly added such diagnoses to the records of numerous residents on a single day. The report also criticized the lack of alternative approaches being tried before resorting to medication, with some staff admitting that drugs were used primarily to make patients easier to manage.
Responses from Stakeholders
The American Health Care Association (AHCA), which represents nursing homes, responded to the report by stating that it does not reflect the practices of all facilities. Holly Harmon, a senior vice president of AHCA, emphasized that the OIG's findings are based on a limited subset of nursing homes and do not represent national trends. She noted that antipsychotic medications can be necessary and beneficial for certain residents when used in conjunction with shared decision-making.
Conversely, patient advocates have expressed strong criticism of the practices highlighted in the report. Toby Edelman, an attorney at the Center for Medicare Advocacy, described the findings as "devastating," confirming ongoing issues with the misuse of antipsychotic drugs in nursing homes.
Conflicting Reports & Gaps
While the OIG report presents a troubling picture of practices in some nursing homes, the AHCA argues that the findings are not indicative of the broader industry. This discrepancy raises questions about the extent of the issue and whether the practices observed in the inspected facilities are widespread or isolated incidents.
Verbatim Quotes
- “We found that nursing homes inappropriately diagnosed schizophrenia to mask their misuse of antipsychotic drugs, artificially inflate their star rating, and skirt established safeguards meant to protect residents,” — Office of Inspector General, U.S. Department of Health and Human Services
- “These OIG reports are based on a very small subset of specifically selected nursing homes and are not indicative of national trends,” — Holly Harmon, Senior Vice President, American Health Care Association
- “The inspector general reports are devastating, confirming that nursing homes continue the decades-long problem of misusing antipsychotic drugs to control residents,” — Toby Edelman, Attorney, Center for Medicare Advocacy
